Also trades as: 0K05.L (LSE) · $vol 0M
MED NYSE
Medifast, Inc.
1W: +3.1%
1M: +6.2%
3M: +29.1%
YTD: +19.6%
1Y: -0.8%
3Y: -83.1%
5Y: -93.0%
$12.49
+0.38 (+3.14%)
Weekly Expected Move ±3.4%
$11
$11
$12
$12
$13
Credit Risk of going bust: lower than 55% of companies Debt: 13.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.18 (down 99%), Medifast, Inc. would be worth roughly what it owes.
Total debt $20.7M against a stock market value of $135.4M.
Distance to default 5.59 (Merton model): prices to 2026-10-26, balance sheet 2026-09-30, debt counted $10.3M (short-term plus half of long-term), stock volatility 49.5%; Altman Z'' 8.59. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.18 (down 99%), Medifast, Inc. would be worth roughly what it owes.
Total debt $20.7M against a stock market value of $135.4M.
Distance to default 5.59 (Merton model): prices to 2026-10-26, balance sheet 2026-09-30, debt counted $10.3M (short-term plus half of long-term), stock volatility 49.5%; Altman Z'' 8.59. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
2 bullish
1 neutral
2 bearish
Articles (7d)
5
Daily Sentiment (7 Days)
Articles (100)
Medifast (MED) Q3 2026 Earnings Call Transcript
Medifast targets Q4 revenue of $55M-$75M as Trilivy rollout continues
Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates
Medifast Non-GAAP EPS of -$0.19 beats by $0.16, revenue of $72.05M beats by $0.75M
Medifast Q3 Earnings on the Horizon: Key Insights for Investors
Best Momentum Stocks to Buy for October 14th
New Strong Buy Stocks for October 14th
Can Hormel Foods Keep Expanding Margins Despite Softer Retail Volumes?
What Actually Keeps Weight Off After a Weight Loss Program
Can Hormel Foods Tackle Input Costs With Pricing and Efficiency?
Can Medifast's Better Client Retention Support Revenue Stabilization?
Why Do You Keep Gaining Weight Back After Losing It
Bank of America Corp DE Purchases New Holdings in Medifast Inc $MED
Will Innovation and Digital Expansion Efforts Drive Clorox's Growth?
Here's Why Shares of BranchOut Food Surge 89% in a Year
What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
Hormel Foods Pricing Strategy: Can It Balance Value and Profitability?
Why Weight Loss Plateaus Happen: 5 Metabolic Causes
Can Hormel Foods' Protein Portfolio Win Over Value-Seeking Consumers?
Boston Beer Uses Innovation, Pricing & Brand Investments for Growth
Constellation Brands' Premiumization and Innovation Aid Growth
Is Laird Superfood (LSF) Stock Outpacing Its Consumer Staples Peers This Year?
MNST's International Sales Surge 35%: Is Global Expansion Paying Off?
Will Strategic Initiatives and Pricing Strength Boost Clorox's Growth?
Can Colgate Revive North America Growth in the Second Half?
AVO Q3 Earnings Beat on Farming Strength and Calavo Contribution
Empowered Funds LLC Takes $701,000 Position in Medifast Inc $MED
BlackRock Inc. Makes New Investment in Medifast Inc $MED
Premiumization and Strong Brands Fuel Constellation Brands' Growth
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth?
BellRing Brands (BRBR) Down 15% Since Last Earnings Report: Can It Rebound?
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?
All You Need to Know About Medifast (MED) Rating Upgrade to Buy
AB InBev Leverages Premiumization and Digital Platforms for Growth
Great Lakes Advisors LLC Invests $548,000 in Medifast Inc $MED
Can Medifast's New Compensation Plan Accelerate Coach Growth?
Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?
Dole's Q2 Earnings Miss Estimates on Higher Fresh Fruit Costs
Medifast (MED) Q2 2026 Earnings Call Transcript
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?
Primo Brands Beats Q2 Earnings Estimates, Raises 2026 Sales Outlook
Archer Daniels Q2 Earnings Beat on Crushing and Ethanol Strength
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves
Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates
Colgate Q2 Earnings Beat Estimates on Strong Margins, Sales Rise 4.9%
Procter & Gamble Q4 Earnings Beat on Productivity, Sales Miss Estimates
Medifast Stock to Post Q2 Earnings: What Investors Should Know
BellRing Brands (BRBR) Expected to Beat Earnings Estimates: Should You Buy?
Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Vita Coco Q2 Earnings Beat on Strong Volume, 2026 Guidance Higher
How Is Post Holdings Rebuilding Its Pet Food Portfolio for Growth?
Can Simpler Pricing Improve Kroger's Customer Retention?
Portfolio Diversification and Premiumization Fuel Molson Coors' Outlook
Will Medifast's Trilivy Launch Unlock a New Growth Chapter?
Archer Daniels Jumps 52% in a Year: Key Factors Behind the Surge
Brand Strength and Innovation Support Brown-Forman's Expansion
Is Fresh Food Becoming Kroger's Biggest Competitive Advantage?
Premiumization and Brand Strength Drive Constellation Brands' Growth
Molson Coors Drives Growth on Premiumization and Other Strategies
Innovation, Pricing and Brand Investments Drive Boston Beer's Growth
Productivity, Innovation and Pricing Drive Newell Brands' Growth
Will Monster Beverage's Expansion Strategy & Innovations Aid?
AB InBev Bolsters Position With Premiumization and Digital Expansion
Brown-Forman's Brand Strength and Premiumization Efforts Fuel Growth
Newell's Productivity & Other Strategic Efforts Bolster Growth
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Will Keurig's Brand Strength & Strategic Actions Power Growth?
Archer Daniels' Innovation, Cost Discipline and Nutrition Aid Growth
AB InBev's Premiumization and Digital Transformation Drive Growth
Will Colgate's Strategic Efforts and Innovation Bolster Growth?
Keurig Dr Pepper Expands Beverage Reach Through Dog Haus Partnership
Will Archer Daniels' Strategic Moves & Cost Savings Aid Growth?
UNFI Q3 Earnings Miss Estimates, Sales Guidance Range Narrowed
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound?
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year?
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
Peer-Reviewed Research Is Redefining Weight Loss Program Standards
3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Why is Medifast stock surging despite weak Q1? $30M cost-cut plan
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026
Medifast (MED) Q1 2026 Earnings Transcript
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
Medifast GAAP EPS of -$0.19 beats by $0.33, revenue of $76M beats by $6.8M
Here are the major earnings after the close Monday
Earnings Scheduled For May 4, 2026
Medifast Q1 2026 Earnings Preview
Medifast's Q1 Earnings on The Horizon: Key Insights for Investors
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
Medifast's New Product Pipeline: Key Catalyst for Comeback?
Hims & Hers Advances a Consumer-Centric Digital Health Platform
Newell Strengthens Capabilities and Innovation to Power Growth